USE OF ETHOGLUCID IN TREATMENT OF ADVANCED MALIGNANT DISEASE.
D000970:Antineoplastic Agents; D001859:Bone Neoplasms; D001943:Breast Neoplasms; D005009:Ethoglucid; D005260:Female; D006258:Head and Neck Neoplasms; D006801:Humans; D007263:Infusions, Parenteral; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007414:Intestinal Neoplasms; D008207:Lymphatic Metastasis; D009062:Mouth Neoplasms; D009369:Neoplasms; D010051:Ovarian Neoplasms; D011379:Prognosis; D013274:Stomach Neoplasms
D000970:Antineoplastic Agents; D005009:Ethoglucid
ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; ETHOGLUCID; INFUSIONS, PARENTERAL; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENOUS; INTESTINAL NEOPLASMS; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; NECK NEOPLASMS; OVARIAN NEOPLASMS; PROGNOSIS; STOMACH NEOPLASMS